Managers / Q1 2022 · view latest →
Vantage Consulting Group Inc
CIK 0001843547 · 3500 PACIFIC AVE, VIRGINIA BEACH, VA, 23451 · 757-491-1200
Summary
Vantage Consulting Group Inc reported $256M in U.S.-listed holdings across 215 positions for Q1 2022.
The portfolio is heavily concentrated: RPRX alone accounts for 41.5% of reported value.
Compared with Q4 2021, the fund opened 6 new positions and exited 22.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 69.8% · $179M
- Other · 29.9% · $77M
- REIT · 0.3% · $771,000
Quarter-over-Quarter Changes full breakdown →
vs Q4 2021 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| CEGConstellation Energy Group Inc | NEW | +7.4K | 7.4K | +$417,000 | $417,000 |
| MOHMolina Healthcare Inc | NEW | +831 | 831 | +$277,000 | $277,000 |
| AALAmerican Airlines Group Inc | NEW | +10.4K | 10.4K | +$191,000 | $191,000 |
| ZYXIQZynex Inc | NEW | +11.0K | 11.0K | +$69,000 | $69,000 |
| Endo International plc | NEW | +18.8K | 18.8K | +$43,000 | $43,000 |
| Barnes & Noble Education Inc | NEW | +11.8K | 11.8K | +$42,000 | $42,000 |
| Intra-Cellular Therapies, Inc. | SOLD OUT | −226.7K | 0 | −$12M | $0 |
| GAPGap Inc | SOLD OUT | −16.3K | 0 | −$287,000 | $0 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2022
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q4 2025 | $20M | 3 | Feb 11, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $11M | 3 | Nov 6, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $6M | 3 | Aug 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $5M | 4 | May 9, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $10M | 5 | Feb 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $11M | 4 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $135M | 191 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $157M | 212 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $149M | 208 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $149M | 200 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $174M | 216 | Aug 11, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $176M | 231 | May 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $169M | 212 | Feb 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $171M | 213 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $178M | 213 | Aug 9, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $256M | 215 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $372M | 231 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $467M | 206 | Nov 10, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $575M | 211 | Aug 11, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $498M | 99 | May 14, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $1.2B | 1,884 | Feb 12, 2021 | 13F-HR | changes · EDGAR ↗ |
Other Included Managers
This filing reports holdings on behalf of 1 additional manager.
- SYNTAX ADVISORS, LLC028-22047
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.